New Zealand markets closed

Moderna, Inc. (MRNA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
148.35-2.53 (-1.68%)
At close: 04:00PM EDT
148.35 0.00 (0.00%)
After hours: 07:59PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close150.88
Bid0.00 x 800
Ask0.00 x 900
Day's range145.36 - 150.36
52-week range115.03 - 217.25
Avg. volume3,661,123
Market cap57.215B
Beta (5Y monthly)1.70
PE ratio (TTM)7.55
EPS (TTM)19.64
Earnings date02 May 2023 - 08 May 2023
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est226.64
  • Motley Fool

    Could CRISPR Therapeutics Become the Next Moderna?

    CRISPR Therapeutics (NASDAQ: CRSP) has a couple of things in common with a company that's made the headlines over the past few years: coronavirus vaccine maker Moderna (NASDAQ: MRNA). Today, CRISPR's market value sits at about $3.4 billion. Since, Moderna has grown to become a $58 billion company, with a blockbuster product and three more potential ones on the horizon.

  • Motley Fool

    3 Things About Moderna That Smart Investors Know

    Moderna (NASDAQ: MRNA) helped some investors make a fortune over the past few years. The stock has climbed more than 400% since March 2020 -- that's when the company's coronavirus vaccine program gained traction. Recently, though, investors have worried about Moderna's post-pandemic revenue, and that's weighed on share performance.

  • Zacks

    Moderna (MRNA) Inks Genetic Medicines Deal With Generation Bio

    Moderna (MRNA) collaborates with Generation Bio to develop non-viral genetic medicines. For this, it leverages the latter's closed-end DNA (ceDNA) and cell-targeted LNPs (ctLNP) technologies.